The present invention provides substituted triazole diamine derivatives as selective kinase or dual-kinase inhibitors and a method for treating or ameliorating a selective kinase or dual-kinase mediated disorder.
本发明提供了取代的三唑二胺衍
生物作为选择性激酶或双重激酶
抑制剂,并提供了一种治疗或改善选择性激酶或双重激酶介导的疾病的方法。